文献速递眼整形与眼眶角膜与眼表疾病

眼眶嗜酸性血管中心性纤维化:6例新病例的临床病理回顾及文献复习

Eosinophilic Angiocentric Fibrosis of the Orbit: A Clinicopathologic Review of 6 Novel Cases With Review of the Literature.
PubMed 文献 · Am J Ophthalmol · 2023-07-24

该回顾性临床病理病例系列于2004至2022年间在单一学术机构收集6例眼眶受累的嗜酸性血管中心性纤维化(EAF)病例,并结合文献复习共总结31例。患者平均就诊年龄49.8岁(范围25-78岁),中位症状持续时间24个月,最常见表现为鼻部症状、眼球突出、眶周肿胀和疼痛。组织病理学特征为血管周围嗜酸性粒细胞丰富浸润及围绕小血管的少炎症性席纹状纤维化,手术减容和免疫抑制剂如利妥昔单抗可稳定病情。

要点

  • 眼眶EAF罕见,多为鼻窦局部延伸所致,但也可原发于眼眶。
  • 常见表现为鼻部症状、眼球突出、眶周肿胀和疼痛,中位症状持续24个月。
  • 病理特征为血管周围嗜酸性粒细胞丰富浸润及围绕小血管的席纹状纤维化。

核心结论

  • 眼眶受累的EAF不常见,组织病理学表现为血管周围嗜酸性粒细胞丰富浸润及围绕小血管的少炎症性席纹状纤维化。
  • 眼眶受累通常由邻近鼻窦局部延伸所致,但也有原发性眼眶受累的报道。
  • 手术减容和免疫抑制剂如利妥昔单抗已被证明可稳定疾病。

研究设计与样本

  • 回顾性临床病理病例系列,收集2004至2022年间单一学术机构中眼眶受累EAF的临床记录和组织病理学数据,并复习当前文献。
  • 共识别6例新病例,结合文献复习共总结31例眼眶受累EAF病例。

主要发现

  • 14例患者为男性,平均就诊年龄49.8岁(范围25-78岁)。
  • 18例患者合并鼻窦受累,13例为原发性眼眶受累。
  • 就诊前中位症状持续时间为24个月,最常见症状为鼻部症状、眼球突出、眶周肿胀和疼痛。
  • 大多数患者接受手术减容以及糖皮质激素和保类固醇药物(如利妥昔单抗)治疗,结果不一。

临床怎么用

  • 手术减容和免疫抑制剂如利妥昔单抗已被证明可稳定疾病。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To describe 6 cases and review the current state of knowledge of eosinophilic angiocentric fibrosis (EAF) involving the orbit. DESIGN: Retrospective clinicopathologic case series and review of the current literature METHODS: Clinical records and histopathologic data of orbit-involving EAF were gathered between 2004 and 2022 from a single academic institution. The patients' presenting clinical symptoms and signs, laboratory data, radiographic studies, and management documentation were collected. RESULTS: Retrospective review identified 6 novel cases, totaling 31 cases of EAF involving the orbit described as of this writing. Fourteen patients were male, and the average age of presentation was 49.8 years (range 25-78 years). Eighteen patients had concurrent sinonasal involvement, whereas 13 had primary orbital involvement. The median duration of symptoms prior to evaluation was 24 months, with nasal symptoms, proptosis, periorbital swelling, and pain being the most common presenting symptoms. The majority of patients underwent surgical debulking, as well as treatment with glucocorticoids and steroid-sparing agents, such as rituximab, with varied results. CONCLUSION: EAF involving the orbit is uncommon. The histopathologic findings include a perivascular, eosinophil-rich infiltrate and a pauci-inflammatory storiform type of fibrosis concentrated around small vessels. Orbital involvement usually results from local extension from adjacent sinuses, but primary orbital involvement has been described. Surgical debulking and immunosuppressive agents such as rituximab have been shown to stabilize disease.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Lin LY, Stone JH, Liou VD, et al. Eosinophilic Angiocentric Fibrosis of the Orbit: A Clinicopathologic Review of 6 Novel Cases With Review of the Literature. Am J Ophthalmol. 2023. PMID: 37495006. doi:10.1016/j.ajo.2023.07.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。